Skip to content

Implant for opioid addiction gets FDA approval

Implant for opioid addiction gets FDA approval

The implant was developed by Titan Pharmaceuticals and is licensed to Braeburn Pharmaceuticals for sale in North America, which is the largest …
See all stories on this topic

Problem gambling and the five‐factor model of personality: A large population‐based study.

A higher level of problem gambling severity appears to be associated with higher scores on neuroticism, and with lower scores on conscientiousness and agreeableness in the Mini-International Personality Item Pool. Brunborg, G. S. , Hanss, D. , Mentzoni, R. A. , Molde, H. , and Pallesen, S. (2016 ) Problem gambling and the five-factor model of personality: a large population-based study . Addictio
See all stories on this topic

Immediate-Release Opioids Get Label Changes, Boxed Warning (FREE)

By Kristin J. Kelley Edited by David G. Fairchild, MD, MPH All immediate-release prescription opioids must now carry a boxed warning about the risks for abuse, addiction, and misuse associated with the painkillers, the FDA announced on Tuesday. The updates include the following: The FDA also added safety information to all prescription opioids, including those used to treat opioid addiction. The
See all stories on this topic

FDA adds addiction, overdose, death to opioid warning labels

BETHESDA, Md., March 22 (UPI) — The U.S. Food and Drug Administration announced it will now require immediate-release opioid painkillers such as OxyContin and Vicodin to carry enhanced warnings about addiction, overdose and death as a result of misuse or abuse of the drugs. The requirement is the second action a government agency has taken in a week against the growing epidemic of opioid abuse a
See all stories on this topic

FDA Orders Warning Labels on Prescription Narcotic Painkillers

By E.J. Mundell and Steven Reinberg HealthDay Reporters TUESDAY, March 22, 2016 (HealthDay News) — Hoping to curb a national epidemic of prescription painkiller abuse, U.S. officials on Tuesday announced that certain drugs will get new “boxed warnings” about the dangers of misuse. The move by the U.S. Food and Drug Administration comes one week after the U.S. Centers for Disease Control and Prev
See all stories on this topic

Published inAddiction

Be First to Comment

Leave a Reply